CD200 and breast cancer: In a murine breast cancer model, it was reported that growth of tumor in an immunocompetent environment “selected” for growth of CD200+ tumor cells, while expression of mCD200 on breast cancer cells (BTAK+) was decreased following growth in immunosuppressed mice [94].